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Studies on Contact Sensitivity to Chromium in the Guinea Pig. The Role 
of Valence in the Formation of the Antigenic Determinant 
URS SIEGENTHALER, M.D., AIRE LAINE, AND LADISLAV POLAK, M.D. 
F. Hoffmann ·La Roche & Co., Ltd., Basle, Switzerland 
Guinea pigs sensitized with either the trivalent chro-
mium chloride or the hexavalent potassium dichromate 
are capable of reacting in vivo and in vitro to challenges 
with both chromium salts. This double reactivity is re-
tained also after repeated restimulations with only 1 of 
these chromium compounds. From the failure to select 
lymphocytes directed specifically against a chromium 
determinant of a particular valence it is concluded that 
by sensitization with chromium salts of different val-
ences a common determinant or closely related deter-
minants are formed. It is suggested that this determinant 
is formed by chromium in the trivalent form. 
Allergic contact eczem a to chromium compounds, besides 
nickel eczem a, is the most frequent occupational dermatos is 
[1,2]. Whereas the role of chromium salts in the induction a nd 
elicitatio n of contact derm'a titis is undisputed, the exact form 
in which chromium partic ipates in the formati on of the a nti-
genic determina n t is still controversial . 
Manuscrip t, rece ived J anuary 29, 1982; accepted for publication April 
28, 1982. 
Reprint requests to: Dr. 1. Polak, F. Hoffmann-La Roche & Co., 
Ltd ., Centra l Research Units (68/252), CH-4002 Basle, Swi tzerland. 
Abbreviation: 
FCA: Freund 's complete adjuvant 
Ch.romium has 6 valence states but only tri - and h exavalent 
salts are sufficiently stable to act as hap tens. Initia lly, clinical 
experience indicated that only hexavalent salts are capable of 
elic iting chromium eczema [3] but, la t er, positive results were 
obtained with trivalent compounds a lso [4]. Therefore , it has 
been concluded [5] that from the clinical point of view the 
ch.romium hypersensitivity is not directed against ciuomium 
compounds of a particular valence and, consequently, t h e more 
precise term is chromium allergy rather than chromate allergy. 
However, this term did not 'remain undisputed and it has been 
suggested that independent hypersensitivities exis t against tri-
valent a nd against hexavalent chromium compounds [6]. 
An attempt to clarify, in animal experiments, the significance 
of chromium valence for the induction and elicitation of allergic 
eczem a failed [7]. It has been shown that both the trivalent 
chromium chloride and the hexavalent potassium dichromate 
possess an equal sensitizing capacity in guinea pigs but the 
latter elicited reactions of a higher intensity than the former 
[7]. 
In t h e present paper we attempted to solve this problem by 
using the technique of positive or negative in vitro and in vivo 
selection of chromium-specific lymphocytes. The r esults of 
these experiments indicate tha t chromium-reactive lympho-
cytes are directed against common or very closely r elated 
determinants. 
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MATERIALS AND METH ODS 
Experimental An.im als 
Inbred strain 2 and partially inbred train Rockefe ller guinea pigs of 
either sex were used. T hey weighed about 350- 400 g when sensitization 
was begun. The animals were bred at the Institute for Biochemical 
Research, Fii Uinsdorf, Switzerland. T hey were fed on peUet d iet sup-
plemented ad libitum with water containing vitamin C. 
The sensit ization was done in the fo llowing manner: 5 injections of 
0.2 ml each of emulsion conta ining either 1 mg/ ml of potassium 
d ichromate (Merck, Darmstadt, FRG ) in Freuild's complete adjuvant 
(FCA) (DIFCO Laboratories, Detroit, Michigan) or 2 mg/ml of chro-
mium chloride (Merck, Darmstadt, FRG) in FCA were given in to the 
footpad and nape of the neck. 
Animals were restimulated once a week by an in traderma l injection 
of 25/-1g either of potassium dichromate or chromium chloride in 0. 1 ml 
0.15 M N aCl solu tion in to the skin of the right fl ank. S imul taneously 
0.02 ml of either 0.5% potassium dichromate or ch romium chloride 
solu tion in 1 % T riton X-100 were applied epicutaneously on the skin of 
the left flank. The boosting was cont inued weekly until a posit ive 
reaction to the hapten was observed. T he animals were then challenged 
epicutaneously with both haptens and the skin inflammation evaluated 
24 hr later according to an arbitrary scale: red, swollen = 2, red, 
contluent = 1, red spots = 0.5. 
Lymphocyte susp ension was prepa red from dra ining lymph nodes 14 
days after sensitization. The cells were teased from the nodes with 
speciaUy constructed forks and fIltered through nylon stocking mesh 
a nd through 5-ml columns containing 1 ml nylon wool (Leuko Pak, 
Fenwal Lab., DIFCO T ravenol Lab. Inc., DeerfIeld, Illinois). T his 
suspension conta ined about 80% T cells, ]0-15% B cells, and 5% mac-
rophages. 
Macrophages 
Normal guinea pigs were injected with 20 ml ligh t paraffin oil 
int raperitoneally (Drake Oil 6-VR Whi te, Penna, Butle r, Pennsylvania). 
T he peri toneal ex udate cells, containing about 70-80% macrophages, 
10-15% lymphocytes, and 10-15% gra nulocytes, were washed out 4 days 
later with Hanks' ba lanced salt solu t ion (GIBCO Biocult, Glasgow, 
Scotland), pooled and irradiated with 3300 1". The cells were then 
incubated 10 min al 37°C with either 3 mg/ml chromium chloride or 
300 /-Ig/ mJ potassium dichromate. After 2 washings the modifIed mac-
rophages were coun ted and corresponding numbers (see below) were 
added to the culture. 
Long· term Culture 
Lymphocytes (2 X 107 ) were cul tured in 10 ml RPMI 1640 medium 
(G IBCO E urope, Glasgow, Scotland) conta ining 50 /-Ig/ ml gentamycin 
(Schering Corporation, Kenilworth, New Jersey), 100 /-Ig/ ml strepto-
mycin and 100 IU penicillin (GIBCO), 10- " M 2-mercaptoetha nol (Sigma 
Chemical Co., Sl. Louis, Missouri) , 2 mM glutamin (GIBCO) , 1 mM 
sodium pyruvate (GIBCO) , 1 mM nonessent ia l a mino acids (GIBCO), 
and 5% heat- inactivated fe tal calf serum (GIBCO) at 37°C in a humified 
atmosphere of 5% CO, and 95% a ir in tissue cul ture flasks (Falcon No. 
3013, Oxnard, Cali fo rnia) . T o the lymphocytes were added either 5 x 
10'; chromium ' '' - or chromiumv'-modifIed macrophages. Twice a week 
4 ml of the cul ture medium was cru·efully replaced by fresh medium 
and on day 7, 5 X 10'; haptenized macrophages were supplied in addi tion 
to the medium exchange. On day 14 the lymphocytes were har vested 
and 1 X 10" ce lls were cul tured wi th either 1 X 10" chromium" '- or · 
chromium v'-mod ified or normal macrophages in 1 m! RPM I 1640 
medium (G IBCO) conta ining 5% heal- inactivated guinea pig serum in 
culture tubes (12 X 75 mm, round-bottom plastic tubes, Falcon). T hree 
days later the cul ture was pu lsed for the last 18 hr with 1 }.lCi of [aHJ-
thymidine (T RA 120, sp act 5 Ci/mM, Radiochemical Centre, Amer-
sham, E ngland) per tube and D NA synthesis was determined by 
counting in a liquid scin t illation spectrometer using glass fiber filters 
(Whatman Inc., Clifton, New York). 
Short-term Culture 
Lymphocytes (5 X 10") were cul tured with either 2 X 10" norma l or 
chromiu m" '- or chromium v'-modified macrophages in 1 ml RPM I 1640. 
Four days later they were pulsed with ["H]-thymidine and counted as 
above. 
RESULTS 
In Vitro Selection of Chromium-Reactive Lymp hocytes 
Lymph node lymphocytes from guinea pigs primed with 
potassium dichromate in FCA exhibi ted a significan t prolifera-
t ive response upon stimulation with either chromium chloride-
modified (Crl ll-M0) or potassium dichromate-modified (Cr VI_ 
M0) macrophages in vitro. This response was stronger upon 
stimulation wit h Crlll-M0 tha n with Crvl-M0 (Table I) . On the 
other hand, lymph node lymphocytes from chromium chloride 
in FCA-sensitized animals failed to show an enhanced in vitro 
D NA synthesis regardless of the valences of chromium salts 
used for haptenization of macrophages. H owever, it should be 
mentioned, that on some occasions lymphocytes from potas-
sium diclu-omate-sensitized guinea pigs also fa iled to become 
stimulated by macrophages modified by chromium sal ts of 
either valence in vitro (data not shown ). 
In fwt her experiments it has been shown that lymphocytes 
t hat responded to the fu·st in vitro stimula tion as well as 
lymphocytes that failed to do so exhibi ted a significan t prolif-
erative response when restimulated twice with chro mium-mod-
ified macrophages dming an expanded cul tm e period (3 weeks). 
This increased ["H]-thymidine incor poration could be elicited 
in lymphocytes from guinea pigs sensitized in vivo with chro-
mium salts of either valence in F CA. 
T he restimulations with Cr"I-M0 induced a significan tly 
higher proliferative response than restimulations with Crvl-M0, 
and this effect was independent of whether the lymphocytes 
originated from chromium chloride- or potassium dichromate-
primed guinea pigs. H owever, no significan t difference in CH]-
thymidine incorporation could be obser ved with respec .0 the 
valence of the haptenized macrophages used for the elic'itaUul. 
of the in vit ro response, alt hough in ali experiments t he Crlll-
M0 elicited a somehow stronger response. 
Selection of in Vivo Response to Challenges with Chromium 
Salts of Different Valences 
All guinea pigs sensit ized wit h potassium dichromate in FCA 
and boosted several t imes epicutaneously a nd int radermaliy 
with the same hapten responded after 4-6 weeks to an epicu-
taneous challenge with t his hexavalent chromium salt (Table 
II) . At the same t ime only 7 of the 11 animals responded to a 
challenge with t he trivalent chromium chloride. T his in flam-
T A BLE 1. Lach of in vitro selection of lymphocytes responding to chromium· modified ma.crophages of different valences 
Treatment in vitro CrCLJ FCA K,Cr,O,fFCA 
Heslimulation in vitro Challenge in vitro cpm S.1. epm .1. 
Cr"'-M0 1,244 ± 335 1.5-2.5 10,596 ± 1,779 3.3-38.6 
none Crv'-M £I 1,419 ± 574 1.4-2.4 4,749 ± 836 3.3-13.0 
Cr"'-M 0 Cr" '-MI!l 88,996 ± 27,313 
6.5-15.9 41 ,060 ± 3,880 6.6-10.8 
Crv'-M£I 48,999 ± 21,495 2.0-7.5 28,162 ± 13,698 2. 1- 11.8 
Crv'-M I!l Cr"' -M £I 8,589 ± 2,832 4.4-5.1 8,256 ± 1,629 3.2- l 2.3 Crv'-M0 6,649 ± 4,462 1.3-4.5 5,807 ± 3,359 3.0-3.2 
Lymph node lymphocytes from guinea pigs sensit ized with either chromilJm" ' chloride (CrC!:.) or potassium dichromate (1(2Cr20 7) in FCA were 
assayed fo r in vit ro DNA synthesis upon stimulation and restimulations with chromium"'- or chromium v'-modified macrophages (Cr"'-M0; CRv,_ 
M0). Resul ts are expressed as mean increments in cpm and as minimal a nd maximal stimulation index (S.L). 
46 SIEGENTHALER, LAINE , AND POLAK Vol. 80, No . 1 
TABLE II. Selection of in vivo response to ch allenges with chromium salts of different valences 
Sensitization 
in vivo 
CrCb in FCA 
Reslimulation 
e.c. + i.d. 
CrC!:, 
Cha llenge 
e.c. 
K 2Cr20 7 
CrCb 
CrCb 
K 2Cr20 7 
Posit ive/Total 
ll/11 
7/ll 
7/10 
3/10 
Number of a nima ls 
Anima ls reac ting positively to both haptens 
Same intensity to both 
haptens 
4/7 (57%) 
3/3 (100%) 
Stronger reaction to chal-
lenge with the sensit izing 
hapten 
3/7 (43%) 
o 
Guinea pigs were sensitized with CrCb or K2Cr20 7 in FCA a nd boosted weekly with the same hapten until pos itive reaction occurred (maximum 
6 weeks) . Then the an imals were cha llenged with both ha ptens simulta neously a nd the reactions evaluated 24 hr later. Abbreviations: e.c. = 
epicutaneously; i.d . = in t radermally. 
matory skin reaction was of t he sam e intensity to both crn'o-
mium compounds in 4 and of a weaker intensity to chromium 
chloride than to potassium dichromate in 3 of the 7 guinea pigs 
responding to both haptens. Four guinea pigs r esponded only 
to potassium dichromate. 
Essentially, the same results were observed in guinea pigs 
sensit ized a nd boosted with the trivalent chromium chloride. 
From the 7 animals that responded to a n epicutaneous chal-
lenge with chromium chloride, 3 responded also to potassium 
dichromate. In th e guinea pigs that responded to both haptens, 
no difference in th e intensity of these reactions could be ob-
served. 
Chromium-modified macrophages used for in vivo sensitiza-
t ion gave errati'c results regardless of the valence of chromium 
salts used for haptenization (data not shown) . 
DISCUSSION 
The aim of our experiments was to determine which is the 
relevant determinant in chromium contact sensitivity with re-
spect to the crn'omium valence. By evaluating the clinical and 
experimental data [7] two possibilities became apparent: either 
one common determinant is formed by sensitization with both 
trivalent or hexavalent chromium compounds, t he latter prob-
ably after conversion into its t rivalent form [8], or the deter-
minant formed by sensitization with hexavalent chromium salts 
differs fro m the one formed by sensitization wi th the trivalent 
salts. 
The first possibility was indicated by the fact that lympho-
cytes obtained from guinea pigs sensitized to a chromium 
compound of a certain valence respond in vitro to stimulations 
with crn'omium compounds of both valences. However, it ap-
peared to be of importance-to exclude this possibility-that 
by application of the hapten in vivo 2 or more determinants 
consisting of crn'omium of different valences are formed. In that 
case, lymphocytes from these animals would also respond both 
in vivo and in vitro to chromium salts of both valences. 
In order to clarify this problem the technique of positive in 
vitro selection was used. It has been shown [9] that lymphocytes 
from guinea pigs sensitized to 2 different antigens and repeat-
edly in vitro stimulated with 1 of them lose their capacity to 
respond to the other one. From these results it is evident that 
in long-term culture only lymphocytes with specificity to the 
hapten used for restimulations sW"vive. Consequently if the 
determinants formed by chromium chloride and potassium 
dichl'omate were different, responsiveness to only the one used 
for restimulations would be maintained. 
This was, however, not the case in oW" experiments. Lymph 
node lymphocytes from animals sensitized with potassium di-
chromate did not lose their ability to respond to chromium 
chloride-modified macrophages (Crlll -M0) even after r epeated 
in vitro restimulations with potassium dichromate-modified 
macrophages (Crv'-M0). On the contrary, the proliferative re-
sponse to Crll l-M0 was always of a slightly higher degree than 
the response to Crv'-M0 regardless of the valence of the chro-
mium compounds used for in vivo priming and for in vitro 
restimulations. The capacity to respond in vitro to both Crlll-
M0 and Crv'-M0 was retained in cultures for up to 6 weeks 
regardless of whether tri- or hexavalent chromium compounds 
were used for sensitization and restimulations. The proliferative 
response to both Crlll-M0 (161,863 cpm) and Crvl-M0 (182,888 
cpm) was only slightly lower than the level of incorporat ion 
reached by mitogenic stimulation with PHA (236,416 cpm) , 
indicating a substantial enrichment of specific antigen-reactive 
cells. 
These results could be considered as evidence for the exist-
ence of 1 common determinant formed by contact with crn'o-
mium compounds of either valence. It is, however, conceivable 
that by in vivo or in vitro contact with a hapten, several 
determinants differing in their protein component(s) are form ed 
[10]. One may speculate that during sensitization with crn'o-
mium salts of different valences several common determinants 
are formed, as well as some additional determinants specific for 
the chromium salt of a particular valence. The existence of 
common determinants might be the reason for the maintenance 
of the simultaneous response to chromium salts of both val-
ences, whereas the additional specific ones may be responsible 
for the differences in intensity of the immune response to a 
pa rticular hapten. 
Another unsolved problem concerning the determinant(s) 
against which chromium hypersensitivity is directed is the 
valence of chromium contained in the antigenic complex. From 
the literature it is known that only trivalent crn'omium com-
pounds are capable of forming covalent bonds with proteins 
[11], which is the precondition for immunogenicity [12]. On the 
other hand , it has been demonstrated that hexavalent chro-
mium is converted into the trivalent form by sulfhydryl group-
containing amino acids in the skin [8]. Since these amino acids 
are also present in the medium used for lymphocyte cultures, 
the conversion may also occur in vitro. 
The idea that the chromium reactive-lymphocytes are di-
rected against the trivalent form is further supported by our 
results, demonstrating the better in vitro stimulatory capacity 
of Crlll-M0 than of Crv'-M0. This hypothesis is further favored 
by our previous reports showing that lymphocytes from duo-
mium-sensitive guinea pigs are capable of producing macro-
phage migration inhibition and skin reactive factors only upon 
stimulation with the trivalent chromium chloride but not wit h 
the hexavalent potassium dicrn'omate [7]. In the direct macro-
phage migration inhibition assay, both chromium salts were 
equally active. 
The higher amounts of chromium chloride necessary for a 
successful lymphocyte stimulation in all these tests could be 
explained by the binding of this protein-active compound to 
some immunologically irrelevant proteins. On the other ha nd, 
the lower amount of potassium dichromate sufficient for effi-
cient haptenization of macrophages and for inhibition of their 
in vitro migration could be understood by assuming that the 
relevant protein binding as well as the antigen processing occurs 
inside these cells [13]. It is known [7] that the hexavalent 
chromium penetrates cell membranes much more easily than 
the trivalent chromium. However, hexavalent crn'omium had to 
be converted into its trivalent form inside t he macrophages in 
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order to be able to bind proteins and to be presented to T cells. 
All of these considerations lead to the conclusion that the 
a nt igenic structure recognized by specific lymphocytes contains 
chromium in its triva lent form since a conversion in the opposite 
direction, i.e., from hexavalent to triva lent, was never demon-
strated. 
The sometimes better in vivo sensitizing capacity of hexava-
lent chromium salts in comparison to t he trivalent ones may be 
th e conseq uence of better penetration in to the skin , which 
facilitates its processing a nd presentation by Langerhans cells 
[14]. 
Our in vivo resul ts showing a certain degree of selectivity 
upon repeated restimuJation with t he particular hapten could 
be interpreted by an existence of 2 entirely different determi-
na nts, one resulting /i'om the sensitization and restimulations 
with potassium dichromate and the other from t he sensit ization 
a nd restimulations with chromium chloride. However, a closer 
a nalysis of the resul ts seems to refute this interpretation. In all 
chromium chloricie- and in a bout 50% of potassium dichromate-
sensitized guinea pigs that reacted to an epicutaneous challenge 
with both haptens, the intensity of these reactions was not 
different, indicating that at least in these a nimals no selection 
for the respective determinant took place. In the other guinea 
pigs reacting only to the hapten used for sensitization and 
restimulations, some nonimmunologic factors such as penetra-
tion capacity, conversion of hexavalent to trivalent forms, and 
protein binding activity may be responsible for t he negative or 
weaker reactions to the chromiqm salt not used for sensitization 
and r estimulations. This view is supported by the lack of 
selection in in vitro experiments, where these factors are of 
lower importance or excluded. 
The other possibility, which has been mentioned above, is 
that besides several common determinan ts some addi t ional 
determina nts which are formed in vivo by application of chro-
mium chloride may differ {i'om those formed by application of 
potassium dichromate. This may be due to t he fact that in vivo 
chromium chloride is bound to the proteins on t he surface of 
macrophages, whereas potassium dichromate forms the rele-
vant conjugates inside the cells after penetrating the membrane 
and convers ion into its trivalent form. This difference in the 
ant igenic formation site is less pronounced in in vitro experi-
ments probably because of the less compbcated mecha nisms of 
haptenization of macrophages in vitro as compared to hapten 
processing a nd presentation in vivo. 
Thus, the resul ts of our in vivo experiments do not contradict 
the possibility that c\U'omium sensitivity is mainly directed 
against 1 common determinant and that this determinant con-
tains chl'omium in its trivalent form . 
Technical assistance of Mrs. V. Weiss and secreLa ria l help of Ms. A. 
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